Trial intelligence / Profile preview

Lisofylline and Islet Transplantation for Type 1 Diabetes

NCT00464555Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Dec 2006
Primary completion
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lisofylline in type 1 diabetes mellitus (T1D), sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2006; status: completed.

02

Drugs

lisofylline
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00464555.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00464555.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call